Avicenna Alliance interview for ANSYS
10/10/2017
BACK
For the Avicenna Alliance, in silico medicine is the obvious connect between the promise of big …
For the Avicenna Alliance, in silico medicine is the obvious connect between the promise of big data and the need for personalised medicine. In an interview for ANSYS, one of the Alliance’s members, the secretariat of the Avicenna Alliance James Kennedy explains how an effective regulatory system for modelling and simulation holds immense opportunities for researchers and companies.